Anlon Healthcare Limited share price
NSE: AHCL · ISIN INE0Y8W01025
Key numbers
- Market cap
- ₹ 1,675 Cr
- Current price
- ₹ 31.51
- 52-week high / low
- ₹ 32 / 10
- Stock P/E
- 47.0
- Book value
- ₹ 5.1
- Dividend yield
- 0.00%
- ROCE
- 21.5%
- ROE
- 18.4%
- Debt to equity
- 0.19
- Sales growth (3 yrs)
- 15.1%
- Profit growth (3 yrs)
- 69.8%
- 1-year return
- 124.8%
About Anlon Healthcare Limited
Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 33 | 52 | 36 | 51 | 88 |
| Operating profit | 6 | 14 | 12 | 15 | 16 |
| Net profit | 4 | 9 | 5 | 11 | 7 |
| EPS (₹) | 0.07 | 0.18 | 0.11 | 0.23 | 0.16 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.